Golimumab monoclonal antibody drug. Targets TNF-alpha. Indications for use include rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis a

---

Golimumab monoclonal antibody drug. Targets TNF-alpha. Indications for use include rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis and ulcerative colitis. Generic name and stylized antibody.

---

Size: 9000px × 4871px
Photo credit: © molekuul.be / Alamy / Afripics
License: Royalty Free
Model Released: No

Keywords: alpha, ankylosing, antibody, arthritis, biological, biosimilar, biotech, biotechnology, colitis, disease, drug, factor, golimumab, immune, immunoglobulin, immunology, immunosuppressive, infusion, inhibitor, injection, inn, mab, monoclonal, necrosis, nomenclature, peptide, protein, psoriatic, rheumatoid, spondylitis, tnf, tnf-, tumor, ulcerative